Talanx AG / Analyst ratings
Price targets
Analyst ratings
1 analysts rated this company in the past 90 days. The average target price is €138.00, this is a change of +27.3% compared to the current price.
-
Berenberg maintains Talanx at 'Buy' - target 138 euros
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg has maintained its "Buy" rating for Talanx with a price target of €138. The insurer continues to deliver better-than-expected results, wrote Michael Huttner in his assessment published Friday. The business model is based on cost efficiency as its most important driver./rob/ag/tih
Publication of the original study: September 25, 2025 / 4:03 p.m. / GMT
First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg raises target for Talanx to 138 euros - 'Buy'
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg raised its price target for Talanx from €125 to €138 following the company's earnings release and maintained its "Buy" rating. The improved company outlook is a good basis for dividend growth, wrote Michael Huttner in a study published Friday. He raised his estimates for net income, especially since the insurer is known for exceeding targets. He also raised his forecast for the dividend payout per share. The valuation of the shares is attractive./rob/tih/mis
Publication of the original study: August 14, 2025 / 4:20 PM / GMT
First distribution of the original study: Date not specified in the study / Time not specified in the study / Time zone not specified in the study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg maintains Talanx at 'Buy' - target 125 euros
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg has maintained a "buy" rating on Talanx with a price target of €125. At in-house marketing events in Luxembourg and Germany, the two most important questions were whether European insurer stocks could rise further and whether the risks for cyber insurance could be reliably quantified, Michael Huttner wrote in an industry assessment published Wednesday. He answered both questions positively. Among the composite insurers, Allianz and AXA are his favorites. Beazley and the life insurer NN Group from Great Britain are also joining the list following the presentation of their strategic plan for 2025 to 2028. Most investors, however, are more interested in quality companies with sustained earnings and dividend growth – in addition to Allianz and AXA, these include Munich Re, Hannover Re, Generali, and Talanx./gl/ag
Publication of the original study: June 10, 2025 / 3:37 p.m. / GMT. First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Deutsche Bank Research raises target for Talanx to 76 euros - 'Hold'
FRANKFURT (dpa-AFX Analyst) - Deutsche Bank Research raised its price target for Talanx from €70 to €76, but maintained its "Hold" rating. The period of rising expectations for net interest income, which has brought higher returns to owners of European bank stocks than to insurers since the beginning of the year, should soon be over, wrote analyst Rhea Shah in an industry outlook published Thursday. The latter are likely to perform comparatively better in 2025. The insurers' stocks are also supported by their robust balance sheets and focus on diversified growth./gl/ag
Publication of the original study: December 5, 2024 / 8:20 a.m. / CET First distribution of the original study: Date not specified in the study / Time not specified in the study / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.